Merrimack Pharmaceuticals (MACK) Fails to deliver data

Key failure to deliver metrics for Merrimack Pharmaceuticals:

• Last SEC data release: 2024-12-13
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Merrimack Pharmaceuticals (MACK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Merrimack Pharmaceuticals (MACK) - since 2017

Merrimack Pharmaceuticals (MACK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sanofi SNY	NZ$5.87 M	NZ$72.77 M	🇫🇷 France
AVEO Oncology AVEO	N/A	NZ$0.04 M	🇺🇸 USA
Geron GERN	NZ$7.13 M	NZ$23.78 M	🇺🇸 USA
Clovis Oncology CLVS	NZ$7.84 M	NZ$96.73 M	🇺🇸 USA
Eterna Therapeutics ERNA	NZ$0.65 M	NZ$0.77 M	🇺🇸 USA